• Денисова М. Ф. д-р мед. наук, професор, керівник відділення проблем захворювань травлення, Державна установа «Інститут педіатрії, акушерства і гінекології ім. акад. О.М. Лук’янової НАМН України», Київ, Україна
  • Букулова Н. Ю. молодший науковий співробітник відділення проблем захворювань травлення, Державна установа «Інститут педіатрії, акушерства і гінекології ім. акад. О.М. Лук’янової НАМН України», Київ, Україна
Keywords: children, ulcerative colitis, diagnostics, clinic


This article presents frequency of occurrence of clinical forms of the disease depending on the localization and activity of the inflammatory process, their age and gender differences, risk factors and disease triggers, based on a retrospective analysis of 116 cases of children with ulcerative colitis at the age of 4-18 years. Comparative clinical, laboratory and endoscopic characteristics of total, segmental and distal colitis have been also analyzed. It was found that clinical activity of total colitis is characterized by more severe course of the disease, accompanied with systemic and local extraintestinal manifestations (OR = 4,504±0,506, p<0.05), more pronounced changes in hemo- and proteinogram parameters (p<0.05). Endoscopic criteria for differences in the clinical forms of ulcerative colitis are the presence of ulcers (OR = 9,667±0,645, p <0,05), erosions (OR = 3,569±0,429, p<0,05), contact bleeding (OR = 4,364± ,444, p< 0.05), changes in the vascular pattern (OR = 3,748±0,477, p<0.05). Correlation analysis of the relationship between clinical (PUCAI), endoscopic (Rachmilewitz index) and laboratory markers of the inflammatory process (leukocytes, platelets, erythrocyte sedimentation rate, γ-globulins, fecal calprotectin, hemoglobin) has been also performed, the criteria of which might be used to monitor the course of the disease and the effectiveness of therapy.


Gorelov A.V., Kanner E.V. Inflammatory bowel diseases in children: peculiarities of the disease course and therapy. Meditsinskiy sovet. 2018; (2): 140-145. (In Russ.) Retrieved from

Horobets A.O. Unspecific ulcerative colitis in children. Perinatologiya i pediatriya. 2015;1(61):74-80. (In Ukr.) DOI 10.15574/PP.2015.61.74

WGO Global Guidelines. Inflammatory Bowel Disease. Update August 2015. Retrieved from

Denisova M.F. Ulcerative colitis and children are a difficult issue for diagnosis and treatment. Health of Ukraine. Pediatria. 2020; 1 (52): 10-11. (In Ukr.) Retrieved from

Denisova M.F. et al. Comparative clinical and paraclinical characteristics of ulcerative colitis and Crohn's disease in children. Zdorov’e Rebenka. 2017; 12(2): 136-141. (In Russ.) DOI: 10.22141/2224-0551.12.2.2017.99769

Denisova M.F. et al. Peculiarities of the course of ulcerative colitis in children at the present stage. Zdorov’e Rebenka. 2017; 12(2): 136-141. (In Ukr.) DOI: 10.22141/2224-0551.12.2.2017.99769

Dorofeev A.E., Vasilenko I.V., Rassokhina O.A. Changes in the expression of MUC2, MUC3, MUC4, TFF3 in the mucous membrane of the large intestine in patients with ulcerative colitis. Gastroenterologia. 2013; 1(47): 80–84. (In Russ.) Retrieved from

Zolotova H.A. et al. Morphological changes in the colon in experimental chronic colitis induced by sodium dextran sulfate. Archiv patologii. 2014; 4: 29-34. (In Russ.)

Zolotova N.A., Makarova O.V. Barrier role of colon mucins in health and ulcerative colitis. Klinicheskaya i eksperimentalnaya morfologiya. 2016; 3 (19): 69-74. (In Russ.)

Rumyantsev V.G. Ulcerative colitis in children. A guide for doctors. М., 2009. С. 20-24. (In Russ.)

Smirnova O. A. et al. Ulcerative colitis: a modern view on some problems. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2017; 5 (141): 4-13. (In Russ.) Retrieved from

Tagirova A.R., Sichinava I.V. Relationship of quality of life indicators and clinical characteristics in inflammatory intestinal diseases in children. Pediatriya named after G. N. Speransky. 2019, Vol. 98 Issue 6, p31-36. (In Russ.)

Chernega N.V. et al. Quality of life of children with ulcerative colitis. Suchasna gastroenterologia. 2017; 6: 7-11. (In Ukr.) Retrieved from

Shenderov B. A. et al. The role of the commensal gut microbiota in the etiopathogenesis of chronic inflammatory diseases: akkermansia muciniphila. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2018; 159(11). (In Russ.) Retrieved from

Shestopalov V.A. et al. Trefoil factors — new markers of gastrointestinal mucosal barrier. Russian Journal of Infection and Immunity. 2019; 9(1): 39–46. (In Russ.) doi: 10.15789/2220-7619-2019-1-39-46

Schigoleva A.M. et al. Inflammatory bowel disease with very early onset. Pediatriya named after G. N. Speransky. 2018; 6: 141-146. (In Russ.)

Dhaliwal J. et al. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. Journal of Crohn's and Colitis. 2020; 14 (4): 445–454, Retrieved from

Hampe J. et al. Linkage of inflammatory desease to human chromosome 6p. Am J Hum Genet. 1996;65(6):1647-1655. doi: 10.1086/302677

Hoekman D.R. et al. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease. Eur J Pediatr. 2016; 175(10): 1335–1342. doi: 10.1007/s00431-016-2762-2

Hugot J. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603. doi: 10.1038/35079107.PMID: 11385576

Iwańczak B. et al. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children. Advances in Medical Sciences. 2020; 65(2): 259-264. Retrieved from

Johansson M.E. Mucus layers in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(11):2124-31. doi: 10.1097/MIB.0000000000000117

Mack D.R. et al. Analysis of Using the Total White Blood Cell Count to Define Severe New Onset Ulcerative Colitis in Children. J Pediatr Gastroenterol Nutr. 2020. doi: 10.1097/MPG.0000000000002797

Rious J. et al. Absence of linkage between inflammatory bowel desease and selected locion chromosomes 3, 7, 12 and 16. Gastroenterology. 1998; 115: 1062-1065.

Roberts S. E. et al. A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe. Journal of Crohn's and Colitis. 2020; 14(6): 1119–1148. Retrieved from

Silva L.C. et al. Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors. Pediatr Gastroenterol Hepatol Nutr. 2020; 23(3): 286–296. doi: 10.5223/pghn.2020.23.3.286

Sun Y. et al. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front. Pediatr. 2019. 7: 432. Retrieved from

Sýkora J. et al. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018; 24(25): 2741-2763. doi: 10.3748/wjg.v24.i25.2741

Takaki Y. et al. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease. 2019. Retrieved from

Turner D. et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care- an Evidence-Based Guideline from ECCO and ESPGHAN. J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):257-291. doi: 10.1097/MPG.0000000000002035.

Turner D. et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut. 2008;57(3):331-8. doi: 10.1136/gut.2007.136481.

Yue B. et al. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System. Microorganisms 2019, 7(10), 440. Retrieved from

How to Cite
Денисова М. Ф., & Букулова Н. Ю. (2020). CLINICAL FORMS OF ULCERATIVE COLITIS AND THEIR FEATURES IN CHILDREN. Science Review, (7(34).